
北美水产养殖疫苗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按疫苗类型(活疫苗、灭活疫苗等)、品种(罗非鱼、鳟鱼、鲑鱼、虾等)、和给药途径(注射疫苗、浸泡疫苗和口服疫苗)
No. of Pages: 111 | Report Code: BMIRE00028128 | Category: Life Sciences
No. of Pages: 111 | Report Code: BMIRE00028128 | Category: Life Sciences
不断增长的水产养殖业正在推动北美水产养殖疫苗市场< /strong>
根据联合国粮食及农业组织发布的《世界渔业和水产养殖状况》报告中的数据据联合国预测,到 2022 年,全球水产食品(不包括藻类)的消费量将比近 60 年前的消费量增加五倍多。全球水产食品消费量从 1961 年的 2800 万吨增加到 2019 年的约 1.58 亿吨。 2019年,自1961年以来,消费年均增长3.0%,而人口增长率为1.6%。由于供给增加、消费者偏好变化和收入增长,人均消费不断增长。 2019年,联合国粮食及农业组织估算了227个国家的人均水产品消费量。从人口来看,2019年消费量低于世界平均水平的国家占世界人口的54%。水产动物消费量的上升正在加速水产养殖业的增长。水产养殖疫苗可降低感染机会并提高产品产量。因此,水产养殖业的发展推动了水产养殖疫苗市场的增长。
北美水产养殖疫苗市场概况
北美水产养殖疫苗市场分为美国、加拿大和墨西哥。该地区的市场增长归因于水产养殖业的增长和对水生动物源性食品的需求激增。美国水产养殖疫苗市场在北美占有重要份额。市场增长的原因是水产养殖产量的增加、水产养殖部门传染病的高发以及新型水产养殖疫苗的不断开发和推出。根据经合组织《2020 年渔业回顾》,2018 年美国鱼类产量为 520 万吨,价值 70.635 亿美元。 83%来自渔业,其中17%来自水产养殖。 2008年至2018年间,产量增长了7%,价值增长了29%。此外,2020年7月,硕腾从Benchmark Holdings, PLC收购了Fish Vet Group,作为其制药业务的战略补充,该业务开发和商业化鱼类疫苗,并为水产养殖提供疫苗接种和诊断服务。 Fish Vet Group 的加入扩大了地理覆盖范围,并改善了诊断专业知识和测试服务,包括环境测试,Pharmaq 的参考实验室 Pharmaq Analytiq 现在可以为主要水产养殖市场的养鱼户提供这些服务。因此,美国水产养殖业各市场主体的不断发展,加上上述因素,将推动美国水产养殖疫苗市场的发展。
< h3>
北美水产养殖疫苗市场细分
< span>
北美水产养殖疫苗市场按疫苗类型、物种、给药途径和国家细分。
根据疫苗类型,北美水产养殖疫苗市场分为活疫苗、灭活疫苗和其他疫苗。 2022年,灭活疫苗细分市场占据最大市场份额。
根据品种,北美水产养殖疫苗市场分为罗非鱼、鳟鱼、鲑鱼、虾等。到 2022 年,鲑鱼细分市场占据最大市场份额。
根据北美水产养殖疫苗市场的给药途径,进行细分分为注射疫苗、浸泡疫苗和口服疫苗。到 2022 年,注射疫苗细分市场占据最大市场份额。
根据国家/地区,北美水产养殖疫苗市场细分为美国、加拿大和墨西哥。 2022 年,美国在水产养殖疫苗市场份额中占据主导地位。
AquaTactics Fish Health;海普拉公司;默克公司有限公司;硕腾公司; Phibro 动物保健公司;和 Elanco Animal Health Inc. 是北美水产养殖疫苗市场的领先公司。
Strategic insights for North America Aquaculture Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 125.36 Million |
Market Size by 2028 | US$ 256.32 Million |
Global CAGR (2022 - 2028) | 12.7% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 疫苗种类
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Aquaculture Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Aquaculture Vaccines Market is valued at US$ 125.36 Million in 2022, it is projected to reach US$ 256.32 Million by 2028.
As per our report North America Aquaculture Vaccines Market, the market size is valued at US$ 125.36 Million in 2022, projecting it to reach US$ 256.32 Million by 2028. This translates to a CAGR of approximately 12.7% during the forecast period.
The North America Aquaculture Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Aquaculture Vaccines Market report:
The North America Aquaculture Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Aquaculture Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Aquaculture Vaccines Market value chain can benefit from the information contained in a comprehensive market report.